Viusid/Alzer efficacy in the treatment of Parkinson’s disease associated fatigue



Título del documento: Viusid/Alzer efficacy in the treatment of Parkinson’s disease associated fatigue
Revista: Belize journal of medicine
Base de datos: PERIÓDICA
Número de sistema: 000418447
ISSN: 2225-8116
Autores: 1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
Instituciones: 1Hospital "Salvador Allende", La Habana. Cuba
2Instituto de Gastroenterología, La Habana. Cuba
Año:
Periodo: Jun
Volumen: 1
Número: 3
Paginación: 14-19
País: Belice
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Experimental, caso clínico
Resumen en inglés Fatigue is a very frequent symptom among patients with Parkinson’s disease (PD) for which there is no effective treatment. In clinical studies of patients with viral and liver diseases, fatigue improvement has been demonstrated with the used of Viusid and Alzer. METHODS. A randomized, double blind and placebo controlled clinical trial was carried out in 100 patients, 50 in each group, from October 2009 to May 2011. Group A or the study group, received combined Viusid and Alzer treatment and group B or the control group, placebo. RESULTS. At 3 months in the study group only 2 showed fatigue (4%), which was maintained at six months and one year, with significant differences when compared to the control group. There was also improvement in fatigue severity, evaluated by PFS. CONCLUSIONS. The combined use of Viusid/Alzer nutritional supplements is effective in PD patient treatment, therefore it should be evaluated in studies with larger number of patients and a methodology that supports this indication
Disciplinas: Medicina
Palabras clave: Neurología,
Terapéutica y rehabilitación,
Enfermedad de Parkinson,
Fatiga,
Viusid,
Alzer,
Síntomas
Keyword: Neurology,
Therapeutics and rehabilitation,
Parkinson disease,
Fatigue,
Viusid,
Alzer,
Symptoms
Texto completo: Texto completo (Ver PDF)